Alzheimer disease (AD) is the most common form of dementia among the elderly and is characterized by progressive loss of memory and cognition. These clinical features are due in part to the increase of reactive oxygen and nitrogen species that mediate neurotoxic effects. The up-regulation of the heme oxygenase-1/biliverdin reductase-A (HO-1/BVR-A) system is one of the earlier events in the adaptive response to stress. HO-1/BVR-A reduces the intracellular levels of pro-oxidant heme and generates equimolar amounts of the free radical scavengers biliverdin-IX alpha (BV)/bilirubin-IX alpha (BR) as well as the pleiotropic gaseous neuromodulator carbon monoxide (CO) and ferrous iron. Two main and opposite hypotheses for a role of the HO-1/BVR-A system in AD propose that this system mediates neurotoxic and neuroprotective effects, respectively. This apparent controversy was mainly due to the fact that for over about 20 years HO-1 was the only player on which all the analyses were focused, excluding the other important and essential component of the entire system, BVR. Following studies from the Butterfield laboratory that reported alterations in BVR activity along with decreased phosphorylation and increased oxidative/nitrosative post-translational modifications in the brain of subjects with AD and amnestic mild cognitive impairment (MCI) subjects, a debate was opened on the real pathophysiological and clinical significance of BVR-A. In this paper we provide a review of the main discoveries about the HO/BVR system in AD and MCI, and propose a mechanism that reconciles these two hypotheses noted above of neurotoxic and the neuroprotective aspects of this important stress responsive system.
Introduction
The aim of this review is to provide a comprehensive analysis about recent results involving the heme oxygenase/biliverdin reductase system with respect to Alzheimer disease (AD) and its arguably earliest form, amnestic mild cognitive impairment (MCI). In particular, a novel point of view regarding the existing paradigm about the HO/BVR-A system is proposed.
The heme oxygenase/biliverdin reductase system: an overview Under physiological conditions, cell homeostasis is finely regulated by a balance between pro-oxidant and anti-oxidant stimuli; however, certain environmental factors, stressors, or diseases may affect this equilibrium and increase the production of reactive oxygen species (ROS) and reactive nitrogen species (RNS). Both ROS and RNS may react with biomolecules including proteins, lipids, carbohydrates, DNA and RNA (Halliwell, 2006) leading to their oxidative damage resulting in cellular dysfunction (Butterfield et al., 2001; Lovell et al., 2001; Mark et al., 1997; Markesbery, 1997; Smith et al., 1994b) .
The heme oxygenase/biliverdin reductase (HO/BVR) system is one of the main and evolutionarily conserved cellular cytoprotectants, whose up-regulation represents an early event in the adaptive response to stress (Poon et al., 2004) . Despite that the initial attention by the scientific community was focused primarily on the ability of this system to degrade heme to be the main, if not the only, function, quite recently numerous different functions have been elucidated.
HO regulation and distribution
Humans and rodents have two HO isozymes, namely HO-1 (about 32 kDa, enzyme) and HO-2 (36 kDa) encoded by the HMOX1 and HMOX2 genes, respectively (Gozzelino et al., 2010) . The third member of the family (HMOX3) has also been described, but it is generally believed that HO-3 is only represented by a pseudogene, with no coding Abbreviations: BVR-A, biliverdin reductase isoform A; HO-1/2, heme oxygenase isoform 1 or 2; HNE, 4-hydroxy-2-nonenal; PC, protein carbonyls; 3-NT, 3-nitrotyrosine; ARE, antioxidant responsive elements. 
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